American Vanguard Corporation (NYSE: AVD) today announced financial results for the second quarter and six months ended June 30, 2023.
3 Months Ended | June 30, 2023 | June 30, 2022 | Change | |||||||||
Net sales | $ | 132,790 | $ | 148,203 | $ | (15,413 | ) | |||||
Net income | $ | (1,053 | ) | $ | 6,830 | $ | (7,883 | ) | ||||
EPS | $ | (0.04 | ) | $ | 0.23 | $ | (0.27 | ) | ||||
Adjusted EBITDA1 | $ | 10,655 | $ | 19,656 | $ | (9,001 | ) | |||||
6 Months Ended | June 30, 2023 | June 30, 2022 | Change | |||||||||
Net sales | $ | 257,674 | $ | 297,797 | $ | (40,123 | ) | |||||
Net income | $ | 865 | $ | 16,765 | $ | (15,900 | ) | |||||
EPS | $ | 0.03 | $ | 0.55 | $ | (0.52 | ) | |||||
Adjusted EBITDA1 | $ | 22,172 | $ | 42,523 | $ | (20,351 | ) | |||||
Eric Wintemute, Chairman and CEO of American Vanguard stated: “During the second quarter of 2023, the Global Agriculture industry experienced a sharp, unexpected drop in procurement activity for crop inputs, as distribution, faced with higher interest rates, destocked inventory in order to limit carrying costs. We believe that this procurement pattern does not represent a loss of demand but, rather, a shift in timing of demand – to be closer to the planting season. We saw similar behavior in our non-crop business, as retailers broke with traditional stocking patterns in favor of just-in-time buying. Further, our businesses in Central America and Brazil faced a flood of low-priced, generic product from China-based suppliers. These factors taken together adversely affected our second quarter financial performance.”
Mr. Wintemute continued: “With stable commodity prices, a strong farm economy and channel inventory of many of our crop products at low levels, we expect that demand should improve significantly over the balance of 2023, as growers prepare for the 2024 planting season. While we are uncertain whether destocking activity has completely run its course, we can say that the distribution channel will need to replenish its stocks, and we are poised to meet the demand. Accordingly, we are revising our 2023 performance targets as indicated below.
2023 Performance Targets
Metric | 2023 Range | 2022 Actual | Change | |||||||
Net sales | $615MM - $625MM | $610MM | flat to up | |||||||
Gross margin % | 32 | % | 32 | % | flat | |||||
Opex as % of sales | 25 | % | 25 | % | flat | |||||
Adjusted EBITDA | $70MM - $75MM | $73.0MM | Similar | |||||||
Net income | $20MM - $24MM | $27.5MM | down | |||||||
Mr. Wintemute concluded: “As a demonstration of our confidence in the company’s prospects, our board of directors has authorized us to enter into a 10b5-1 plan under which we may purchase up to $7.5 million of our common stock on the open market. We continue to see enduring value in our equity and believe that this repurchase program is a prudent allocation of capital. We encourage you to join us for our upcoming earnings call, during which we will give you a more detailed presentation of our first-half performance and full-year targets.”
Conference Call
Eric Wintemute, Chairman & CEO and David T. Johnson, VP & CFO, will conduct a conference call focusing on the financial results and strategic themes at 5 pm ET on August 8, 2023. Interested parties may participate in the call by dialing 713-481-1320. Please call in 10 minutes before the call is scheduled to begin and ask for the American Vanguard call. The conference call will also be webcast live via the News and Media section of the Company’s web site at www.american-vanguard.com. To listen to the live webcast, go to the web site at least 15 minutes early to register, download and install any necessary audio software. If you are unable to listen live, the conference call will be archived on the Company’s web site.
About American Vanguard
American Vanguard Corporation is a diversified specialty and agricultural products company that develops, manufactures, and markets solutions for crop protection and nutrition, turf and ornamentals management, commercial and consumer pest control. Over the past 20 years, through product and business acquisitions, the Company has expanded its operations into 17 countries and now has over 1,000 product registrations in 56 nations worldwide. Its strategy rests on three growth initiatives – i) Core Business (through innovation of conventional products), ii) Green Solutions (with over 130 biorational products – including fertilizers, microbials, nutritionals and non-conventional products) and iii) Precision Agriculture innovation (including SIMPAS prescriptive application and Ultimus measure/record/verify technologies). American Vanguard is included on the Russell 2000® and Russell 3000® Indexes and the Standard & Poor’s Small Cap 600 Index. To learn more about American Vanguard, please reference the Company’s web site at www.american-vanguard.com.
The Company, from time to time, may discuss forward-looking information. Except for the historical information contained in this release, all forward-looking statements are estimates by the Company’s management and are subject to various risks and uncertainties that may cause results to differ from management’s current expectations. Such factors include weather conditions, changes in regulatory policy and other risks as detailed from time-to-time in the Company’s SEC reports and filings. All forward-looking statements, if any, in this release represent the Company’s judgment as of the date of this release.
AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands, except share data) (Unaudited) | ||||||||
ASSETS | ||||||||
June 30,
| December 31,
| |||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 14,632 | $ | 20,328 | ||||
Receivables: | ||||||||
Trade, net of allowance for doubtful accounts of $6,135 and $5,136, respectively | 151,479 | 156,492 | ||||||
Other | 11,473 | 9,816 | ||||||
Total receivables, net | 162,952 | 166,308 | ||||||
Inventories | 237,587 | 184,190 | ||||||
Prepaid expenses | 17,546 | 15,850 | ||||||
Income taxes receivable | 5,436 | 1,891 | ||||||
Total current assets | 438,153 | 388,567 | ||||||
Property, plant and equipment, net | 73,452 | 70,912 | ||||||
Operating lease right-of-use assets | 23,724 | 24,250 | ||||||
Intangible assets, net | 178,624 | 184,664 | ||||||
Goodwill | 48,219 | 47,010 | ||||||
Other assets | 10,193 | 10,769 | ||||||
Deferred income tax assets, net | 293 | 141 | ||||||
Total assets | $ | 772,658 | $ | 726,313 | ||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||
Current liabilities: | ||||||||
Accounts payable | $ | 78,876 | $ | 69,000 | ||||
Customer prepayments | 27,368 | 110,597 | ||||||
Accrued program costs | 80,333 | 60,743 | ||||||
Accrued expenses and other payables | 13,273 | 20,982 | ||||||
Current operating lease liabilities | 5,493 | 5,279 | ||||||
Total current liabilities | 205,343 | 266,601 | ||||||
Long-term debt, net | 160,750 | 51,477 | ||||||
Long-term operating lease liabilities | 18,884 | 19,492 | ||||||
Other liabilities, net of current installments | 4,923 | 4,167 | ||||||
Deferred income tax liabilities, net | 13,683 | 14,597 | ||||||
Total liabilities | 403,583 | 356,334 | ||||||
Commitments and contingent liabilities | ||||||||
Stockholders' equity: | ||||||||
Preferred stock, $.10 par value per share; authorized 400,000 shares; none issued | — | — | ||||||
Common stock, $0.10 par value per share; authorized 40,000,000 shares; issued 34,643,674 shares at June 30, 2023 and 34,446,194 shares at December 31, 2022 | 3,464 | 3,444 | ||||||
Additional paid-in capital | 106,719 | 105,634 | ||||||
Accumulated other comprehensive loss | (6,131 | ) | (12,182 | ) | ||||
Retained earnings | 327,911 | 328,745 | ||||||
Less treasury stock at cost, 5,438,093 shares at June 30, 2023 and 5,029,892 shares at December 31, 2022 | (62,888 | ) | (55,662 | ) | ||||
Total stockholders’ equity | 369,075 | 369,979 | ||||||
Total liabilities and stockholders' equity | $ | 772,658 | $ | 726,313 | ||||
AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (In thousands, except per share data) (Unaudited) | ||||||||||||||||
For the Three Months
| For the Six Months
| |||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||
Net sales | $ | 132,790 | $ | 148,203 | $ | 257,674 | $ | 297,797 | ||||||||
Cost of sales | (89,881 | ) | (98,872 | ) | (176,230 | ) | (197,070 | ) | ||||||||
Gross profit | 42,909 | 49,331 | 81,444 | 100,727 | ||||||||||||
Operating expenses | (39,155 | ) | (38,518 | ) | (74,423 | ) | (75,165 | ) | ||||||||
Operating income | 3,754 | 10,813 | 7,021 | 25,562 | ||||||||||||
Change in fair value of equity investment | (55 | ) | (486 | ) | ||||||||||||
